Filter
143
Text search:
generics
Featured
Recommendations
14
New Publications
39
Language
Document type
No document type
65
Studies & Reports
43
Guidelines
22
Strategic & Response Plan
6
Manuals
4
Situation Updates
2
Infographics
1
Countries / Regions
Global
10
India
5
Kenya
5
Ghana
4
South Africa
4
Ukraine
4
Philippines
3
Tanzania
3
Namibia
3
Sierra Leone
2
Nigeria
2
Senegal
2
Ethiopia
2
Uganda
2
Haiti
2
Rwanda
2
Indonesia
2
Malawi
2
Lesotho
2
Latin America and the Carribbean
2
Western and Central Europe
2
Burkina Faso
1
Zimbabwe
1
Germany
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Botswana
1
Myanmar / Burma
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Albania
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
20
Public Health
10
Pharmacy & Technologies
9
Women & Child Health
2
Toolboxes
Pharmacy
22
HIV
21
AMR
19
NCDs
12
TB
5
COVID-19
5
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Conflict
2
Refugee
2
Planetary Health
2
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Background
Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension medicines to identify areas for improvement in access
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety and comparative cost-effectiveness. They are intended to be available in functioning health
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Lancet Glob Health 2021 Published Online December 13, 2021 https://doi.org/10.1016/S2214-109X(21)00463-
NEMLIST | Sixth Edition | February 2016
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
Supply of essential medicines and health technologies (6 April 2020)
This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on measures to strengthen the health system response to C
...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
